Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI +1.48%19 Median PS Value is ₹0.00 as of Sep. 01, 2026. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 267 Healthcare Providers & Services companies, Pramodini Medicare ranks worse than 374531.46% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Pramodini Medicare's Median PS Value or its related term are showing as below:
NSE:PRAMODINI's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.72 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Pramodini Medicare (NSE:PRAMODINI) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Pramodini Medicare's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
116.50
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare Median PS Value Related Terms
Pramodini Medicare Median PS Value Historical Data
* Premium members only.
The historical data trend for Pramodini Medicare's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare Median PS Value Chart
Pramodini Medicare Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Median PS Value
0.00
0.00
0.00
0.00
Pramodini Medicare Quarterly Data
Mar23
Mar24
Mar25
Dec25
Mar26
Median PS Value
0.00
0.00
0.00
0.00
0.00
NSE:PRAMODINI vs HCA, THC, EHC: Median PS Value Comparison
For the Medical Care Facilities subindustry, Pramodini Medicare's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pramodini Medicare Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Pramodini Medicare's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
Pramodini Medicare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.09.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pramodini Medicare (NSE:PRAMODINI) has a Median PS Value of ₹0.00 as of Sep. 01, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Pramodini Medicare and its competitors. According to the industry distribution chart, Pramodini Medicare ranks #999999 out of 267 companies in the Healthcare Providers & Services industry.
Is Pramodini Medicare's Median PS Value too high?
Pramodini Medicare's current Median PS Value is ₹0.00. Based on the distribution chart, Pramodini Medicare ranks #999999 out of 267 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #999999 out of 267 companies for Median PS Value. This places Pramodini Medicare in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.72, based on 267 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Pramodini Medicare and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current Median PS Value is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current Median PS Value of ₹0.00. The current Median PS Value is ₹0.00. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current Median PS Value is ₹0.00 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
